RPG Life Sciences forms new API subsidiary, appoints CFO

RPG Life Sciences' board of directors, meeting on December 15, 2025, approved the incorporation of a new wholly-owned subsidiary, "RPG Active Pharma Limited," to focus on manufacturing and marketing active pharmaceutical ingredients (API) and related products. This subsidiary, with an authorized share capital of INR 1,00,000 and paid-up capital of INR 95,000, will be a related party to the company.

The API business, which contributed INR 90.24 crores (13.8%) to the company’s turnover and INR 90.61 crores (17.1%) to its net worth in FY25, will be transferred to the new WOS as a going concern. This transfer is expected to complete by March 31, 2026, for an approximate consideration of INR 50,00,00,000, based on book value. RPG Life Sciences plans to invest up to INR 105 crore in the WOS for capitalization and operations.

Concurrently, Amol Lone has been appointed as the chief financial officer and key managerial personnel, effective December 15, 2025. Lone brings over two decades of experience in corporate finance and holds an MBA in International Business.